4CPS-150 Use of adalimumab for hidradenitis suppurativa

BACKGROUND: Adalimumab is an antibody against tumour necrosis factor-α currently indicated for moderate to severe hidradenitis suppurative (HS). PURPOSE: To assess the effectiveness and safety of adalimumab in patients with HS. MATERIAL AND METHODS: A retrospective study of patients with HS and trea...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Hosp Pharm
Autori principali: Gil-Sierra, MD, Garciadeparedes-Esteban, JC, Rios-Sanchez, E, Briceño-Casado, MDP, Palomo-Palomo, C, Diaz-Navarro, J, Rey, EJ Alegre-Del, Martinez-Diaz, C, Lopez-Vallejo, JF, Borrero-Rubio, JM
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2018
Soggetti:
Section 4: Clinical pharmacy services
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535183/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.241
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi